Day: July 22, 2019

Viveve Announces Top-line Results of LIBERATE-International Trial for SUI, Q2 Transition to New U.S. Commercial Model, and Pursuit of Financial and Strategic Alternatives

Arcutis, Inc. Announces Positive Top Line Results for Phase 2b Clinical Trial Evaluating ARQ-151 as a Potential Topical Treatment for Plaque Psoriasis

Both tested doses of ARQ-151 demonstrated statistically significant superiority over vehicle Favorable safety and tolerability in this patient population ARQ-151...

error: Content is protected !!